1. Home
  2. ALVOW vs MMS Comparison

ALVOW vs MMS Comparison

Compare ALVOW & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALVOW
  • MMS
  • Stock Information
  • Founded
  • ALVOW 2013
  • MMS 1975
  • Country
  • ALVOW Luxembourg
  • MMS United States
  • Employees
  • ALVOW 999
  • MMS N/A
  • Industry
  • ALVOW Biotechnology: Biological Products (No Diagnostic Substances)
  • MMS Business Services
  • Sector
  • ALVOW Health Care
  • MMS Consumer Discretionary
  • Exchange
  • ALVOW Nasdaq
  • MMS Nasdaq
  • Market Cap
  • ALVOW N/A
  • MMS N/A
  • IPO Year
  • ALVOW N/A
  • MMS 1997
  • Fundamental
  • Price
  • ALVOW $2.15
  • MMS $66.84
  • Analyst Decision
  • ALVOW
  • MMS Buy
  • Analyst Count
  • ALVOW 0
  • MMS 1
  • Target Price
  • ALVOW N/A
  • MMS $90.00
  • AVG Volume (30 Days)
  • ALVOW 15.0K
  • MMS 697.3K
  • Earning Date
  • ALVOW 02-27-2025
  • MMS 05-07-2025
  • Dividend Yield
  • ALVOW N/A
  • MMS 1.80%
  • EPS Growth
  • ALVOW N/A
  • MMS 54.03
  • EPS
  • ALVOW N/A
  • MMS 4.65
  • Revenue
  • ALVOW $393,919,000.00
  • MMS $5,381,831,000.00
  • Revenue This Year
  • ALVOW N/A
  • MMS $0.90
  • Revenue Next Year
  • ALVOW N/A
  • MMS $3.08
  • P/E Ratio
  • ALVOW N/A
  • MMS $14.32
  • Revenue Growth
  • ALVOW 517.92
  • MMS 8.01
  • 52 Week Low
  • ALVOW $2.33
  • MMS $63.77
  • 52 Week High
  • ALVOW $2.33
  • MMS $93.97
  • Technical
  • Relative Strength Index (RSI)
  • ALVOW N/A
  • MMS 42.76
  • Support Level
  • ALVOW N/A
  • MMS $65.53
  • Resistance Level
  • ALVOW N/A
  • MMS $72.92
  • Average True Range (ATR)
  • ALVOW 0.00
  • MMS 2.25
  • MACD
  • ALVOW 0.00
  • MMS 0.37
  • Stochastic Oscillator
  • ALVOW 0.00
  • MMS 33.55

About ALVOW Alvotech Warrant

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Share on Social Networks: